Impaired quality of life in patients commencing radiotherapy for cancer

Monika Janda, Beth Newman, Andreas Obermair, Hedwig Woelfl, Michael Trimmel, Heidi Schroeckmayr, Joachim Widder, Richard Poetter

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)

Abstract

Background: This study tested a three-item questionnaire to measure global quality of Life (QOL) and pain in patients commencing radiotherapy, based on items from the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 instrument.

Patients and Methods: In a pretest, the EORTC QLQ-C30 and the three-item short questionnaire were administered to 100 patients, yielding similar global QOL and pain scores. After the pretest, the three-item questionnaire was administered to 1,837 patients prior to first radiotherapy treatment.

Results: 254 (13.8%) patients with impaired QOL were identified. These patients had a mean global QOL score of 32.6 compared to 72.4 (p <0.001) found in patients with satisfactory QOL. Patients with impaired QOL were also more Likely <60 years and treated for lung, gastrointestinal or head and neck cancer or advanced, metastatic cancer.

Conclusion: This brief questionnaire addresses important aspects of QOL, is feasible to use in a clinical setting and therefore represents a potentially useful too[ for detecting those patients who may benefit from further evaluation and/or psychosocial support.

Original languageEnglish
Pages (from-to)78-83
Number of pages6
JournalStrahlentherapie und onkologie
Volume180
Issue number2
DOIs
Publication statusPublished - Feb-2004
Externally publishedYes

Keywords

  • cancer
  • radiotherapy
  • quality of life
  • screening
  • psychosocial support
  • ADVANCED BREAST-CANCER
  • EORTC QLQ-C30
  • EUROPEAN-ORGANIZATION
  • PALLIATIVE RADIOTHERAPY
  • RADIATION-THERAPY
  • DEPRESSION SCALE
  • HOSPITAL ANXIETY
  • PROGNOSTIC VALUE
  • NECK-CANCER
  • LUNG-CANCER

Fingerprint

Dive into the research topics of 'Impaired quality of life in patients commencing radiotherapy for cancer'. Together they form a unique fingerprint.

Cite this